Drreddys Laboratories reported INR179.71B in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ani Pharmaceuticals ANIP:US USD 309.38M 13.02M
Aurora Cannabis Inc ACB:CN CAD 681.83M 63.29M
Bayer BAYN:GR EUR 38.41B 1.14B
Canopy Growth Corp WEED:CN CAD 1.54B 55.4M
Catalent CTLT:US USD 2.7B 218M
Corcept Therapeutics CORT:US USD 452.4M 33.36M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Hikma Pharmaceutical HIK:LN USD 2.14B 50M
Horizon Pharma HZNP:US USD 3.41B 208.92M
Lannett LCI:US USD 264.66M 25.46M
Lonza Group LONN:SW CHF 5.7B 251M
Novartis NOVN:VX USD 36.95B 1.19B
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Phibro Animal Health PAHC:US USD 570.08M 3.85M
Prestige Brands PBH:US USD 336.65M 12.04M
Richter Gedeon RICHT:HB HUF 602.15B 82.15B
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical TEVA:IT USD 11.45B 711M